Results for tag: "Glomerulosclerosis Drug"

Glomerulosclerosis is a type of kidney disorder that affects the glomeruli, the tiny filters in the kidneys that help remove waste from the blood. Glomerulosclerosis drugs are used to treat this condition and can help slow the progression of the disease. These drugs work by reducing inflammation and preventing the buildup of proteins in the glomeruli. They can also help reduce the risk of complications such as high blood pressure and kidney failure. The glomerulosclerosis drug market is a subset of the larger liver and kidney disorders drugs market. This market is composed of a variety of drugs used to treat a range of conditions, including glomerulosclerosis. These drugs are typically prescribed by a doctor and can be taken orally or intravenously. Some companies in the glomerulosclerosis drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more